MPT: Gout Drug Raises Safety Concerns With Death Excess in Trial

ACC Conference Reporter

ACC.18 | ORLANDO, FL — The two most common preventive medications for gout — febuxostat (Uloric) and allopurinol -- came out largely similar for cardiovascular outcomes, except for a worrying and unexplained higher risk of mortality with febuxostat, the CARES trial showed. Read More >>>



Keywords: ACC18, ACC Annual Scientific Session


< Back to Listings